Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasms, Pancreas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04705818
What this trial is testing

Combining Epigenetic And Immune Therapy to Beat Cancer.

Who this might be right for
Advanced Solid TumorAdvanced Colorectal CarcinomaAdvanced Soft-tissue Sarcoma+2 more
Institut Bergonié 164
Early research (Phase 1)Looking for participantsNCT07619313
What this trial is testing

AB801 in Combination With Chemotherapy and Immunotherapy for the Treatment of Patients With Borderline Resectable, Locally Advanced or Metastatic Cholangiocarcinoma or Pancreatic Cancer

Who this might be right for
Borderline Resectable Pancreatic Ductal AdenocarcinomaLocally Advanced CholangiocarcinomaLocally Advanced Pancreatic Adenocarcinoma+5 more
Jonsson Comprehensive Cancer Center 46
Testing effectiveness (Phase 2)Looking for participantsNCT06445062
What this trial is testing

Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

Who this might be right for
Colorectal CancerCRCPancreatic Ductal Adenocarcinoma+3 more
Revolution Medicines, Inc. 1,130
Not applicableUnknownNCT04636788
What this trial is testing

Circulating Extracellular Exosomal Small RNA as Potential Biomarker for Human Pancreatic Cancer

Who this might be right for
Pancreas Adenocarcinoma
Huazhong University of Science and Technology 102
Testing effectiveness (Phase 2)Looking for participantsNCT04789486
What this trial is testing

Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer

Who this might be right for
Non-small Cell Lung CancerAdvanced Pancreatic AdenocarcinomaUnresectable Pancreatic Cancer+1 more
Dana-Farber Cancer Institute 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06166589
What this trial is testing

Second-line Zimberelimab and SIRIOX Chemotherapy for Patient With Previously AG Chemotherapy Treated Pancreatic Cancer

Who this might be right for
Previously AG Chemotherapy Treated Pancreatic Cancer
Shanghai Zhongshan Hospital 19
Early research (Phase 1)UnknownNCT01218880
What this trial is testing

Study With M2ES and Gemcitabine for Patients With Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Beijing Protgen Biotechnology Development Co., Ltd. 21
Not applicableStudy completedNCT04789980
What this trial is testing

Good Choice of pALliative Chemotherapy to Patient With Pancreatic Cancer ; GemcitAbine Therapy vs FOLFORINOX therapY

Who this might be right for
Locally Advanced Pancreatic CancerMetastatic Pancreatic Cancer
Boryung Pharmaceutical Co., Ltd 799
Not applicableUnknownNCT04773769
What this trial is testing

Study of Guanábana Leaves for The Treatment of Patients With Gastric, Gastroesophageal Junction, Pancreatic and Colorectal Adenocarcinomas; Hepatocellular Carcinoma, and Low Grade Lymphomas

Who this might be right for
Gastric AdenocarcinomaAdenocarcinoma of the Gastroesophageal JunctionHepatocellular Carcinoma+3 more
Auxilio Mutuo Cancer Center 54
Testing effectiveness (Phase 2)Ended earlyNCT04203641
What this trial is testing

L-DOS47 Plus Doxorubicin in Advanced Pancreatic Cancer

Who this might be right for
Pancreas Cancer
Helix BioPharma Corporation 28
Not applicableUnknownNCT02734680
What this trial is testing

IORT Followed by CCRT or SBRT for Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 70
Very early researchLooking for participantsNCT05916261
What this trial is testing

Personalized Tumor Vaccines and Pabolizumab in Patients With Advanced Pancreatic Cancer

Who this might be right for
Advanced Pancreatic Cancer
Ruijin Hospital 54
Post-approval studies (Phase 4)Not Yet RecruitingNCT07302841
What this trial is testing

Tunlametinib + AG + Cetuximab β as First-Line Therapy for Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer Non-resectable
Tianjin Medical University Cancer Institute and Hospital 28
Not applicableWithdrawnNCT03707444
What this trial is testing

A Pilot Trial of Scrambler Therapy for Pain Associated With Pancreas Cancer

Who this might be right for
Cancer PancreasPain SyndromeCancer Related Pain
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Not applicableStudy completedNCT02332863
What this trial is testing

Comparison of Back-loaded vs Preloaded Fiducial Needles in EUS-guided Fiducial Marker Placement in Pancreatic Cancer.

Who this might be right for
Pancreatic Cancer
University of Colorado, Denver 44
Not applicableLooking for participantsNCT06605404
What this trial is testing

Pan-tumor MRD Study

Who this might be right for
Muscle Invasive Bladder Urothelial CarcinomaEsophageal CancerGastric and Gastroesophageal Junction (GEJ) Adenocarcinoma+4 more
Paradigm Health 1,350
Testing effectiveness (Phase 2)Study completedNCT00550836
What this trial is testing

Erlotinib and Gemcitabine With or Without Panitumumab in Treating Patients With Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Alliance for Clinical Trials in Oncology 104
Testing effectiveness (Phase 2)Study completedNCT00397787
What this trial is testing

Sunitinib in Treating Patients With Metastatic Pancreatic Cancer That Progressed After First-Line Therapy With Gemcitabine

Who this might be right for
Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasRecurrent Pancreatic Cancer+1 more
National Cancer Institute (NCI) 64
Early research (Phase 1)Study completedNCT00480584
What this trial is testing

A Phase I Trial of Capecitabine in Combination With Gemcitabine and Erlotinib for Advanced Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Carcinoma
H. Lee Moffitt Cancer Center and Research Institute 20
Testing effectiveness (Phase 2)Study completedNCT01560949
What this trial is testing

Preoperative Folfirinox, Radiation Therapy for Resectable Adenocarcinoma of the Pancreas

Who this might be right for
Pancreatic Cancer
M.D. Anderson Cancer Center 34
Next Page